Subtopic Deep Dive
Adrenergic Signaling in Cancer
Research Guide
What is Adrenergic Signaling in Cancer?
Adrenergic signaling in cancer refers to β-adrenergic receptor activation by stress hormones like norepinephrine that promotes tumor progression, metastasis, angiogenesis, and immune suppression.
Chronic stress activates β-adrenergic pathways enhancing VEGF expression and metastasis in preclinical models (Thaker et al., 2006, 1267 citations). Beta-blockers like propranolol inhibit these effects, reducing tumor growth and improving survival in breast and ovarian cancer studies (Cole and Sood, 2011, 647 citations; Barron et al., 2011, 510 citations). Over 10 key papers document these mechanisms with population-based and mouse model evidence.
Why It Matters
Adrenergic signaling drives metastasis via VEGF upregulation and immune modulation, as shown in ovarian carcinoma mouse models where chronic stress increased tumor growth (Thaker et al., 2006). Population studies link beta-blocker use to reduced breast cancer mortality and improved relapse-free survival in triple-negative cases (Barron et al., 2011; Melhem-Bertrandt et al., 2011). Propranolol repurposing shows anti-metastatic potential, with clinical trials testing perioperative beta-blockade to lower recurrence after prostatectomy (Biki et al., 2008). These findings support beta-blockers as adjuvant therapies in stress-influenced cancers.
Key Research Challenges
Translating Preclinical to Clinical
Mouse models show propranolol blocks adrenergic-driven metastasis (Thaker et al., 2006), but human trials face dosing and timing issues. Population studies report survival benefits (Barron et al., 2011), yet causality remains unproven due to confounding hypertension treatments.
Mechanistic Heterogeneity Across Cancers
β-adrenergic effects vary by cancer type, promoting angiogenesis in ovarian models (Thaker et al., 2006) but inflammation in breast cancer (Cole and Sood, 2011). Immune modulation via myelopoiesis differs in stress models (Powell et al., 2013), complicating targeted interventions.
Perioperative Stress Management
Anesthesia techniques influence adrenergic signaling and recurrence (Biki et al., 2008), but optimal protocols integrating beta-blockers are undefined. Stress reduction interventions improve survival (Andersen et al., 2008), yet scalable methods for surgical settings lack validation.
Essential Papers
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Premal H. Thaker, Liz Y. Han, Aparna A. Kamat et al. · 2006 · Nature Medicine · 1.3K citations
The updated landscape of tumor microenvironment and drug repurposing
Ming-Zhu Jin, Weilin Jin · 2020 · Signal Transduction and Targeted Therapy · 1.2K citations
Molecular Pathways: Beta-Adrenergic Signaling in Cancer
Steve W. Cole, Anil K. Sood · 2011 · Clinical Cancer Research · 647 citations
Abstract Beta-adrenergic signaling has been found to regulate multiple cellular processes that contribute to the initiation and progression of cancer, including inflammation, angiogenesis, apoptosi...
Anesthetic Technique for Radical Prostatectomy Surgery Affects Cancer Recurrence
Barbara Biki, Edward J. Mascha, Denis C. Moriarty et al. · 2008 · Anesthesiology · 603 citations
Background Regional anesthesia and analgesia attenuate or prevent perioperative factors that favor minimal residual disease after removal of the primary carcinoma. Therefore, the authors evaluated ...
Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of myelopoiesis
Nicole Powell, Erica K. Sloan, Michael T. Bailey et al. · 2013 · Proceedings of the National Academy of Sciences · 560 citations
Significance Chronic exposure to adverse social environments is associated with increased risk of disease, and stress-related increases in the expression of proinflammatory genes appear to contribu...
Beta Blockers and Breast Cancer Mortality: A Population- Based Study
Thomas I. Barron, Roisín M. Connolly, Linda Sharp et al. · 2011 · Journal of Clinical Oncology · 510 citations
Purpose Preclinical studies have demonstrated that antagonism of β 2 -adrenergic signaling inhibits several pathways necessary for breast tumor progression and metastasis. A series of population-ba...
Psychologic intervention improves survival for breast cancer patients
Barbara L. Andersen, Hae‐Chung Yang, William B. Farrar et al. · 2008 · Cancer · 486 citations
Abstract BACKGROUND. The question of whether stress poses a risk for cancer progression has been difficult to answer. A randomized clinical trial tested the hypothesis that cancer patients coping w...
Reading Guide
Foundational Papers
Start with Thaker et al. (2006) for chronic stress-tumor growth mechanisms in ovarian models (1267 citations), then Cole and Sood (2011) for comprehensive β-pathway review, followed by Barron et al. (2011) for clinical beta-blocker evidence.
Recent Advances
Jin and Jin (2020, 1172 citations) on tumor microenvironment repurposing; Pongratz and Straub (2014, 400 citations) on sympathetic inflammation responses.
Core Methods
Chronic stress mouse models (Thaker 2006); population-based cohorts (Barron 2011); leukocyte transcriptomics (Powell 2013); propranolol interventions; anesthesia randomization (Biki 2008).
How PapersFlow Helps You Research Adrenergic Signaling in Cancer
Discover & Search
Research Agent uses searchPapers and citationGraph on 'propranolol ovarian cancer Thaker' to map 1267-citation foundational work (Thaker et al., 2006), then findSimilarPapers reveals beta-blocker studies like Barron et al. (2011). exaSearch uncovers propranolol-anesthesia links from Biki et al. (2008).
Analyze & Verify
Analysis Agent applies readPaperContent to extract VEGF pathways from Cole and Sood (2011), verifies claims with CoVe against Thaker et al. (2006), and runs PythonAnalysis on survival data from Barron et al. (2011) for GRADE-assessed hazard ratios with statistical tests.
Synthesize & Write
Synthesis Agent detects gaps in perioperative beta-blocker trials post-Biki et al. (2008), flags contradictions between preclinical (Thaker et al., 2006) and clinical data. Writing Agent uses latexEditText, latexSyncCitations for Thaker/Barron refs, and latexCompile for review manuscripts with exportMermaid for signaling pathway diagrams.
Use Cases
"Extract survival statistics from beta-blocker breast cancer studies and plot hazard ratios."
Research Agent → searchPapers('beta blocker breast cancer') → Analysis Agent → readPaperContent(Barron 2011, Melhem-Bertrandt 2011) → runPythonAnalysis(pandas HR meta-analysis, matplotlib forest plot) → researcher gets GRADE-verified CSV plot.
"Write LaTeX review section on adrenergic VEGF mechanisms with citations."
Synthesis Agent → gap detection(Thaker 2006 + Cole 2011) → Writing Agent → latexEditText(draft text) → latexSyncCitations(10 papers) → latexCompile(PDF) → researcher gets compiled section with diagram.
"Find code for adrenergic signaling simulations from related papers."
Research Agent → searchPapers('adrenergic signaling cancer model') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Python sims for norepinephrine-VEGF models.
Automated Workflows
Deep Research workflow scans 50+ papers via citationGraph from Thaker et al. (2006), generating structured reports on beta-blocker efficacy with GRADE scores. DeepScan's 7-step chain verifies mechanisms: readPaperContent(Cole 2011) → CoVe → runPythonAnalysis(survival meta). Theorizer builds hypotheses linking perioperative stress (Biki 2008) to immune modulation (Powell 2013).
Frequently Asked Questions
What defines adrenergic signaling in cancer?
β-adrenergic receptors activated by norepinephrine promote tumor angiogenesis, metastasis, and immune suppression (Cole and Sood, 2011).
What methods study these pathways?
Mouse stress models measure VEGF/tumor growth (Thaker et al., 2006); population cohorts assess beta-blocker survival (Barron et al., 2011); anesthesia trials track recurrence (Biki et al., 2008).
What are key papers?
Thaker et al. (2006, 1267 citations) on ovarian models; Cole and Sood (2011, 647 citations) on pathways; Barron et al. (2011, 510 citations) on breast mortality.
What open problems exist?
Randomized trials confirming beta-blocker causality beyond observational data (Barron 2011); optimal perioperative dosing; cancer-type specificity (Cole 2011).
Research Cancer, Stress, Anesthesia, and Immune Response with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Adrenergic Signaling in Cancer with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers